Global and Japan Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Avacopan
1.2.3 Immune Globulin
1.2.4 Rituximab Biosimilar
1.2.5 Others
1.3 Market by Application
1.3.1 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Microscopic Polyangiitis (MPA) Treatment Market Perspective (2015-2026)
2.2 Global Microscopic Polyangiitis (MPA) Treatment Growth Trends by Regions
2.2.1 Microscopic Polyangiitis (MPA) Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Microscopic Polyangiitis (MPA) Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Market Size
3.1.1 Global Top Microscopic Polyangiitis (MPA) Treatment Players by Revenue (2015-2020)
3.1.2 Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Players (2015-2020)
3.2 Global Microscopic Polyangiitis (MPA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Microscopic Polyangiitis (MPA) Treatment Revenue
3.4 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio
3.4.1 Global Microscopic Polyangiitis (MPA) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
3.5 Key Players Microscopic Polyangiitis (MPA) Treatment Area Served
3.6 Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
3.7 Date of Enter into Microscopic Polyangiitis (MPA) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Type (2015-2026)
4.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Type (2015-2020)
4.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Type (2021-2026)
5 Microscopic Polyangiitis (MPA) Treatment Breakdown Data by Application (2015-2026)
5.1 Global Microscopic Polyangiitis (MPA) Treatment Historic Market Size by Application (2015-2020)
5.2 Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2026)
6.2 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
6.3 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
6.4 North America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2026)
7.2 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
7.3 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
7.4 Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2026)
8.2 China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
8.3 China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
8.4 China Microscopic Polyangiitis (MPA) Treatment Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2026)
9.2 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
9.3 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
9.4 Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size (2015-2026)
10.2 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020)
10.3 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020)
10.4 Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Celltrion Inc
11.1.1 Celltrion Inc Company Details
11.1.2 Celltrion Inc Business Overview
11.1.3 Celltrion Inc Microscopic Polyangiitis (MPA) Treatment Introduction
11.1.4 Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020))
11.1.5 Celltrion Inc Recent Development
11.2 ChemoCentryx Inc
11.2.1 ChemoCentryx Inc Company Details
11.2.2 ChemoCentryx Inc Business Overview
11.2.3 ChemoCentryx Inc Microscopic Polyangiitis (MPA) Treatment Introduction
11.2.4 ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
11.2.5 ChemoCentryx Inc Recent Development
11.3 Sandoz International GmbH
11.3.1 Sandoz International GmbH Company Details
11.3.2 Sandoz International GmbH Business Overview
11.3.3 Sandoz International GmbH Microscopic Polyangiitis (MPA) Treatment Introduction
11.3.4 Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
11.3.5 Sandoz International GmbH Recent Development
11.4 Teijin Pharma Ltd
11.4.1 Teijin Pharma Ltd Company Details
11.4.2 Teijin Pharma Ltd Business Overview
11.4.3 Teijin Pharma Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
11.4.4 Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
11.4.5 Teijin Pharma Ltd Recent Development
11.5 TTY Biopharm Company Ltd
11.5.1 TTY Biopharm Company Ltd Company Details
11.5.2 TTY Biopharm Company Ltd Business Overview
11.5.3 TTY Biopharm Company Ltd Microscopic Polyangiitis (MPA) Treatment Introduction
11.5.4 TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
11.5.5 TTY Biopharm Company Ltd Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Avacopan
Table 4. Key Players of Immune Globulin
Table 5. Key Players of Rituximab Biosimilar
Table 6. Key Players of Others
Table 7. Global Microscopic Polyangiitis (MPA) Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2015-2020)
Table 11. Global Microscopic Polyangiitis (MPA) Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Table 13. Microscopic Polyangiitis (MPA) Treatment Market Market Trends
Table 14. Microscopic Polyangiitis (MPA) Treatment Market Drivers
Table 15. Microscopic Polyangiitis (MPA) Treatment Market Challenges
Table 16. Microscopic Polyangiitis (MPA) Treatment Market Restraints
Table 17. Global Microscopic Polyangiitis (MPA) Treatment Revenue by Players (2015-2020) (US$ Million)
Table 18. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players (2015-2020)
Table 19. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019)
Table 20. Global Microscopic Polyangiitis (MPA) Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Microscopic Polyangiitis (MPA) Treatment Product Solution and Service
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 25. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Type (2015-2020)
Table 26. Global Microscopic Polyangiitis (MPA) Treatment Revenue Market Share by Type (2021-2026)
Table 27. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2015-2020)
Table 28. Global Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 29. Global Microscopic Polyangiitis (MPA) Treatment Market Size Share by Application (2021-2026)
Table 30. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 31. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 32. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 33. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 34. North America Microscopic Polyangiitis (MPA) Treatment Market Size by Country (US$ Million) (2015-2020)
Table 35. North America Microscopic Polyangiitis (MPA) Treatment Market Share by Country (2015-2020)
Table 36. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 37. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 38. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 39. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 40. Europe Microscopic Polyangiitis (MPA) Treatment Market Size by Country (US$ Million) (2015-2020)
Table 41. Europe Microscopic Polyangiitis (MPA) Treatment Market Share by Country (2015-2020)
Table 42. China Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 43. China Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 44. China Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 45. China Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 46. China Microscopic Polyangiitis (MPA) Treatment Market Size by Region (US$ Million) (2015-2020)
Table 47. China Microscopic Polyangiitis (MPA) Treatment Market Share by Region (2015-2020)
Table 48. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 49. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 50. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 51. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 52. Japan Microscopic Polyangiitis (MPA) Treatment Market Size by Country (US$ Million) (2015-2020)
Table 53. Japan Microscopic Polyangiitis (MPA) Treatment Market Share by Country (2015-2020)
Table 54. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Type (2015-2020) (US$ Million)
Table 55. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Type (2015-2020)
Table 56. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Application (2015-2020) (US$ Million)
Table 57. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size by Country (US$ Million) (2015-2020)
Table 59. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Share by Country (2015-2020)
Table 60. Celltrion Inc Company Details
Table 61. Celltrion Inc Business Overview
Table 62. Celltrion Inc Product
Table 63. Celltrion Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (US$ Million)
Table 64. Celltrion Inc Recent Development
Table 65. ChemoCentryx Inc Company Details
Table 66. ChemoCentryx Inc Business Overview
Table 67. ChemoCentryx Inc Product
Table 68. ChemoCentryx Inc Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (US$ Million)
Table 69. ChemoCentryx Inc Recent Development
Table 70. Sandoz International GmbH Company Details
Table 71. Sandoz International GmbH Business Overview
Table 72. Sandoz International GmbH Product
Table 73. Sandoz International GmbH Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (US$ Million)
Table 74. Sandoz International GmbH Recent Development
Table 75. Teijin Pharma Ltd Company Details
Table 76. Teijin Pharma Ltd Business Overview
Table 77. Teijin Pharma Ltd Product
Table 78. Teijin Pharma Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (US$ Million)
Table 79. Teijin Pharma Ltd Recent Development
Table 80. TTY Biopharm Company Ltd Company Details
Table 81. TTY Biopharm Company Ltd Business Overview
Table 82. TTY Biopharm Company Ltd Product
Table 83. TTY Biopharm Company Ltd Revenue in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020) (US$ Million)
Table 84. TTY Biopharm Company Ltd Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Type: 2020 VS 2026
Figure 2. Avacopan Features
Figure 3. Immune Globulin Features
Figure 4. Rituximab Biosimilar Features
Figure 5. Others Features
Figure 6. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Microscopic Polyangiitis (MPA) Treatment Report Years Considered
Figure 11. Global Microscopic Polyangiitis (MPA) Treatment Market Size (US$ Million), YoY Growth 2015-2026
Figure 12. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Regions (2021-2026)
Figure 14. Global Microscopic Polyangiitis (MPA) Treatment Market Share by Players in 2019
Figure 15. Global Top Microscopic Polyangiitis (MPA) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Microscopic Polyangiitis (MPA) Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Microscopic Polyangiitis (MPA) Treatment Revenue in 2019
Figure 17. North America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. United States Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Canada Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Germany Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. France Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. U.K. Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Italy Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Russia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Nordic Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Rest of Europe Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. China Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Japan Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. South Korea Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Southeast Asia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. India Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Australia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Rest of Asia-Pacific Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Latin America Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Mexico Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Brazil Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Turkey Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Saudi Arabia Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. UAE Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Rest of Middle East & Africa Microscopic Polyangiitis (MPA) Treatment Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Celltrion Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 45. ChemoCentryx Inc Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 46. Sandoz International GmbH Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 47. Teijin Pharma Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 48. TTY Biopharm Company Ltd Revenue Growth Rate in Microscopic Polyangiitis (MPA) Treatment Business (2015-2020)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed